BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34579191)

  • 1. A Novel Recombinant Newcastle Disease Vaccine Improves Post-
    Marcano VC; Cardenas-Garcia S; Diel DG; Antoniassi da Silva LH; Gogal RM; Miller PJ; Brown CC; Butt SL; Goraichuk IV; Dimitrov KM; Taylor TL; Williams-Coplin D; Olivier TL; Stanton JB; Afonso CL
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579191
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel Recombinant Newcastle Disease Virus-Based
    Dimitrov KM; Taylor TL; Marcano VC; Williams-Coplin D; Olivier TL; Yu Q; Gogal RM; Suarez DL; Afonso CL
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
    Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
    Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
    Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
    Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Protection Conferred by Recombinant Newcastle Disease Virus Expressing Infectious Bronchitis Spike Protein.
    Zegpi RA; He L; Yu Q; Joiner KS; van Santen VL; Toro H
    Avian Dis; 2020 Mar; 64(1):53-59. PubMed ID: 32267125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.
    Wen G; Li L; Yu Q; Wang H; Luo Q; Zhang T; Zhang R; Zhang W; Shao H
    PLoS One; 2017; 12(2):e0172812. PubMed ID: 28234989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chicken interleukin-2 by a highly virulent strain of Newcastle disease virus leads to decreased systemic viral load but does not significantly affect mortality in chickens.
    Susta L; Diel DG; Courtney S; Cardenas-Garcia S; Sundick RS; Miller PJ; Brown CC; Afonso CL
    Virol J; 2015 Aug; 12():122. PubMed ID: 26253150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Recombinant La Sota Vaccine Strain Expressing Multiple Epitopes of Infectious Bronchitis Virus (IBV) Protects Specific Pathogen-Free (SPF) Chickens against IBV and NDV Challenges.
    Tan L; Wen G; Qiu X; Yuan Y; Meng C; Sun Y; Liao Y; Song C; Liu W; Shi Y; Shao H; Ding C
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31683905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
    Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
    Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.